- Home
- SOFI vs ICLR Comparison
SOFI vs ICLR Comparison
Compare SOFI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOFI
- ICLR
- Stock Information
- Founded
- SOFI 2011
- ICLR 1990
- Country
- SOFI United States
- ICLR Ireland
- Employees
- SOFI N/A
- ICLR N/A
- Industry
- SOFI Diversified Financial Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SOFI Finance
- ICLR Health Care
- Exchange
- SOFI Nasdaq
- ICLR Nasdaq
- Market Cap
- SOFI 11.9B
- ICLR 11.4B
- IPO Year
- SOFI N/A
- ICLR 1998
- Fundamental
- Price
- SOFI $18.53
- ICLR $150.10
- Analyst Decision
- SOFI Buy
- ICLR Buy
- Analyst Count
- SOFI 14
- ICLR 12
- Target Price
- SOFI $14.15
- ICLR $204.18
- AVG Volume (30 Days)
- SOFI 75.7M
- ICLR 1.2M
- Earning Date
- SOFI 07-29-2025
- ICLR 07-23-2025
- Dividend Yield
- SOFI N/A
- ICLR N/A
- EPS Growth
- SOFI N/A
- ICLR 11.53
- EPS
- SOFI 0.43
- ICLR 9.19
- Revenue
- SOFI $2,771,415,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- SOFI $26.36
- ICLR N/A
- Revenue Next Year
- SOFI $19.40
- ICLR $2.10
- P/E Ratio
- SOFI $43.66
- ICLR $16.41
- Revenue Growth
- SOFI 23.62
- ICLR N/A
- 52 Week Low
- SOFI $6.01
- ICLR $125.10
- 52 Week High
- SOFI $18.92
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- SOFI 74.60
- ICLR 64.00
- Support Level
- SOFI $17.35
- ICLR $142.89
- Resistance Level
- SOFI $18.92
- ICLR $155.25
- Average True Range (ATR)
- SOFI 0.75
- ICLR 4.60
- MACD
- SOFI 0.28
- ICLR 0.67
- Stochastic Oscillator
- SOFI 90.84
- ICLR 81.93
About SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.